Substance
TEZACAFTOR
Global reference: every product and company linked to this substance.
- cas: 1152311-62-0
- ncit: C152581
- pubchem_cid: 46199646
- rxnorm: 1999382
- unii: 8RW88Y506K
SYMKEVI COMPONENT TEZACAFTOR · tezacaftor [INN] · TEZACAFTOR [USAN] · Tezacaftor [WHO-DD] · TRIKAFTA COMPONENT TEZACAFTOR · VX-661
Revenue by product (3)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED COMMON STOCK | TRIKAFTA (COPACKAGED) | Q2 2026 | $2.5B* |
| VERTEX PHARMACEUTICALS INCORPORATED COMMON STOCK | ALYFTREK | Q2 2026 | $573.6M* |
| VERTEX PHARMACEUTICALS INCORPORATED COMMON STOCK | SYMDEKO (COPACKAGED) | Q4 2023 | $27.8M* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (3)
- ALYFTREK · VERTEX PHARMACEUTICALS INCORPORATED COMMON STOCK
- SYMDEKO (COPACKAGED) · VERTEX PHARMACEUTICALS INCORPORATED COMMON STOCK
- TRIKAFTA (COPACKAGED) · VERTEX PHARMACEUTICALS INCORPORATED COMMON STOCK